DEA Scraps License Of Opioid Dealer, 4 Years After Court Order

The US Drug Enforcement Administration (DEA) stripped one of the nation’s largest drug distributors of its license to sell highly addictive painkillers after determining it failed to flag thousands of suspicious orders at the height of the opioid crisis, Joshua Goodman and Jim Mustian reported for the Associated Press (AP).

Photo Insert: The action against Morris & Dickson Co. becomes effective in 90 days.

The action against Morris & Dickson Co. that threatens to put it out of business came two days after an AP investigation found the DEA allowed the company to keep shipping drugs for nearly four years after a judge recommended the harshest penalty for its “cavalier disregard” of rules aimed at preventing opioid abuse.

DEA acknowledged the time it took to issue its final decision was “longer than typical for the agency” but blamed Morris & Dickson in part for holding up the process by seeking delays due to the COVID-19 pandemic and its lengthy pursuit of a settlement that the agency said it had considered.

The order becomes effective in 90 days, allowing more time to negotiate a settlement. The company was founded in 1840.

DEA Administrator Anne Milgram said in the 68-page order that Morris & Dickson failed to accept full responsibility for its past actions, which included shipping 12,000 unusually large orders of opioids to pharmacies and hospitals between 2014 and 2018.

During this time, the company filed just three suspicious order reports with the DEA. Milgram specifically cited testimony of then-president Paul Dickson Sr. in 2019 that the company’s compliance program was “dang good” and he didn’t think a “single person has gotten hurt by (their) drugs.”

WEEKLY FEATURE : MVP Group Keeps Lights On During Pandemic